Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Pharmacopeia receives patent coverage for drug discovery technology

Oct. 25, 1996

P&U reports compounds for improving drug bioavailability

Oct. 25, 1996

Funding for Genetronics' electroporation delivery technology

Oct. 18, 1996

Regeneron-Pharmacopeia drug discovery collaboration

Oct. 18, 1996

Peptidomimetic compounds disclosed by University of Pennsylvania

Oct. 18, 1996

Palatin receives grants for the development of peptide-based therapeutics and diagnostics

Oct. 11, 1996

Geron licenses technologies for use in the treatment of age-related diseases

Oct. 11, 1996

Patent coverage for new gene expression system

Oct. 11, 1996

Patent allowance for SuperGen technology for cancer drug formulation

Oct. 11, 1996

Alkermes' RMP-7 advances through clinical trials

Oct. 11, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....